Skip to main content
. 2014 May 28;2014:297203. doi: 10.1155/2014/297203

Figure 1.

Figure 1

Patient flow during the study. On day 1 (V1), patients were asked to participate in the study. 25 patients received ectoine nasal spray, and 25 patients received beclomethasone nasal spray for a treatment period of 14 ± 2 days. All 50 patients finished the study with the final study visit V2.